NO133806B - - Google Patents

Download PDF

Info

Publication number
NO133806B
NO133806B NO4629/69A NO462969A NO133806B NO 133806 B NO133806 B NO 133806B NO 4629/69 A NO4629/69 A NO 4629/69A NO 462969 A NO462969 A NO 462969A NO 133806 B NO133806 B NO 133806B
Authority
NO
Norway
Prior art keywords
formula
trans
solution
methyl
benzene
Prior art date
Application number
NO4629/69A
Other languages
English (en)
Norwegian (no)
Other versions
NO133806C (ko
Inventor
G Saucy
J W Scott
C J Sharp
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to NO751208A priority Critical patent/NO751208L/no
Publication of NO133806B publication Critical patent/NO133806B/no
Publication of NO133806C publication Critical patent/NO133806C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005Retrosteroids (9 beta 10 alfa)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO4629/69A 1968-11-22 1969-11-21 NO133806C (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO751208A NO751208L (ko) 1968-11-22 1975-04-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77831468A 1968-11-22 1968-11-22

Publications (2)

Publication Number Publication Date
NO133806B true NO133806B (ko) 1976-03-22
NO133806C NO133806C (ko) 1976-06-30

Family

ID=25112933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4629/69A NO133806C (ko) 1968-11-22 1969-11-21

Country Status (19)

Country Link
US (1) US3700661A (ko)
JP (1) JPS5022031B1 (ko)
AT (8) AT294331B (ko)
BE (4) BE742087A (ko)
BR (4) BR6914375D0 (ko)
CA (2) CA918669A (ko)
CH (10) CH529774A (ko)
DE (3) DE1958601A1 (ko)
DK (4) DK130117B (ko)
ES (5) ES373752A1 (ko)
FI (1) FI47572C (ko)
FR (4) FR2024920A1 (ko)
GB (9) GB1298218A (ko)
IE (1) IE33651B1 (ko)
IL (2) IL33369A (ko)
NL (4) NL6917499A (ko)
NO (1) NO133806C (ko)
PH (2) PH10667A (ko)
SE (5) SE376422B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984428A (en) * 1968-11-22 1976-10-05 Hoffmann-La Roche Inc. Isoxazolyl-substituted perhydrobenzindenes
US3991084A (en) * 1970-08-26 1976-11-09 Hoffmann-La Roche Inc. Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor
US3994930A (en) * 1970-08-26 1976-11-30 Hoffmann-La Roche Inc. 6-(3-Cyanopropyl)-2-vinyl tetrahydropyran-2-ol and its tautomer
US3900491A (en) * 1972-06-05 1975-08-19 Hoffmann La Roche 1-(4-isoxazolyl)-7-hydroxy-2-hydroxyimino heptanes
US3873561A (en) * 1972-06-05 1975-03-25 Hoffmann La Roche 7-(4-Isoxazolyl)-5-oxo-heptanals
US3873562A (en) * 1972-06-05 1975-03-25 Hoffmann La Roche 1-(4-Isoxazolyl)-7-hydroxy-3-heptanones
US3994926A (en) * 1973-05-24 1976-11-30 Hoffmann-La Roche Inc. Aryl ketals of polycyclic oxo compounds and processes
US3855209A (en) * 1973-09-04 1974-12-17 Eastman Kodak Co Synthesis of indolininium methine dyes
US4054583A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Process for converting 2,7-dihydroxy-5-isopropylidene-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin to trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo(b,d)pyran-9-one
EP0841926B1 (en) * 1995-08-02 2003-03-26 Smithkline Beecham Corporation Endothelin receptor antagonists
US6030970A (en) * 1995-08-02 2000-02-29 Smithkline Beecham Corporation Endothelin receptor antagonists
EP0885217A4 (en) * 1996-02-01 1999-04-21 Smithkline Beecham Corp ENDOTHELIN RECEPTOR ANTAGONISTS
US6174906B1 (en) 1999-10-01 2001-01-16 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
BE742090A (ko) 1970-05-25
JPS5022031B1 (ko) 1975-07-28
DE1958600C3 (de) 1980-08-07
CH537938A (de) 1973-07-31
GB1298218A (en) 1972-11-29
DK130117C (ko) 1975-06-09
SE364715B (ko) 1974-03-04
BE742087A (ko) 1970-05-25
AT292694B (de) 1971-09-10
FI47572C (fi) 1974-01-10
CA944770A (en) 1974-04-02
CH567490A5 (ko) 1975-10-15
AT295757B (de) 1972-01-25
CH568314A5 (ko) 1975-10-31
ES401968A1 (es) 1976-04-16
CH567489A5 (ko) 1975-10-15
GB1298214A (en) 1972-11-29
BR6914372D0 (pt) 1973-02-08
NL6917554A (ko) 1970-05-26
BE742088A (ko) 1970-05-25
DK127975B (da) 1974-02-11
DE1958600A1 (de) 1970-07-09
IE33651L (en) 1970-05-22
GB1298211A (en) 1972-11-29
ES373753A1 (es) 1973-04-16
NO133806C (ko) 1976-06-30
PH11342A (en) 1977-11-02
CH574890A5 (ko) 1976-04-30
AT292695B (de) 1971-09-10
NL6917499A (ko) 1970-05-26
GB1298219A (en) 1972-11-29
DE1958608A1 (de) 1970-06-18
AT294832B (de) 1971-12-10
US3700661A (en) 1972-10-24
ES373751A1 (es) 1972-02-01
GB1298213A (en) 1972-11-29
FR2024920A1 (ko) 1970-09-04
PH10667A (en) 1977-08-02
BR6914374D0 (pt) 1973-04-19
FR2024918A1 (ko) 1970-09-04
IE33651B1 (en) 1974-09-18
AT299463B (de) 1972-06-26
CH537942A (de) 1973-07-31
NL6917557A (ko) 1970-05-26
ES373752A1 (es) 1973-04-16
CH529774A (de) 1972-10-31
GB1298215A (en) 1972-11-29
SE354657B (ko) 1973-03-19
AT304772B (de) 1973-01-25
DK130117B (da) 1974-12-23
ES373754A1 (es) 1972-04-01
CH578547A5 (ko) 1976-08-13
FR2024919A1 (ko) 1970-09-04
SE361887B (ko) 1973-11-19
FI47572B (ko) 1973-10-01
SE376422B (ko) 1975-05-26
DK126655B (da) 1973-08-06
GB1298217A (en) 1972-11-29
BR6914373D0 (pt) 1973-02-08
GB1298212A (en) 1972-11-29
DE1958600B2 (de) 1979-11-29
BR6914375D0 (pt) 1973-04-19
AT294331B (de) 1971-11-25
DK129090B (da) 1974-08-19
IL42366A0 (en) 1973-07-30
NL6917574A (ko) 1970-05-26
DE1958601A1 (de) 1970-06-18
CH561192A5 (ko) 1975-04-30
IL33369A0 (en) 1970-01-29
GB1298216A (en) 1972-11-29
IL33369A (en) 1973-10-25
CA918669A (en) 1973-01-09
AT308981B (de) 1973-07-25
FR2030078A1 (ko) 1970-10-30
SE355801B (ko) 1973-05-07
BE742089A (ko) 1970-05-25
CH567523A5 (ko) 1975-10-15

Similar Documents

Publication Publication Date Title
NO133806B (ko)
US3822254A (en) Synthesis of 25-hydroxycholesterol
EP1973893A2 (en) Process for preparing crystalline forms of orlistat
Djerassi et al. Steroidal Sapogenins. XXII. 1 Steroids. XXXIV. 2 Degradation of 11-Oxygenated Sapogenins. Synthesis of Allopregnane-3β, 11β-diol-20-one and Allopregnane-3β, 11α-diol-20-one
Hootele et al. The Cycloaddition Reaction Between Styrene and 2, 3, 4, 5‐Tetrahydropyridine 1‐Oxide
HU182158B (en) Process for preparing 17-/hydroxy-acetyl/-steroid derivatives
US4325879A (en) Amino-14 steroid derivatives and process for preparation of the same
KR101446825B1 (ko) 아로마타제 억제제의 제조 방법
US4044004A (en) Total steroid synthesis employing substituted isoxazole derivatives
DK171578B1 (da) Fremgangsmåde til fremstilling af 17alfa-ethynyl-17beta-hydroxy-18-methyl-4,15-østradien-3-on og mellemprodukter til anvendelse ved fremgangsmåden
US3480621A (en) Steroid ketal
DK170751B1 (da) Fremgangsmåder til fremstilling af 5-amino-5-deoxy-1,2-0-isopropyliden-alfa-D-glucofuranose og nojirimycin
CA1289135C (en) 13.alpha.-ALKYLGONAN-DELTA _____-5,10-EPOXIDES
Karmas Synthesis of steroidal 3, 5-dieno [3, 4-b] dithianes
US4064173A (en) 9,10-Seco-steroids
Gent et al. 27. Stereochemical investigation of cyclic bases. Part IV. Hofmann degradation of 6α-and 6β-cholestanyltrimethylammonium salts
US2803632A (en) Synthesis of steroids
Counsell et al. Anabolic agents: derivatives of 2-halo-5α-androst-1-ene
Uhle N-methylsolasodine
Batres et al. Steroids. CLVII. 1 6-Aminoandrostanes
Edwards et al. Steroids. CCL. 1 The Synthesis of 2-Methylenehydrocortisone2
US3455907A (en) Process and intermediates for the manufacture of 3-keto-17-ketal steroids
US3933870A (en) Synthesis of A-ring aromatic steroids
JPH0745498B2 (ja) t−ブチルエルゴリン誘導体
US4045490A (en) 9,10-Seco-steroid preparation